• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文会议>International Congress of Andrology >Hypogonadism and Diabetes
【24h】

Hypogonadism and Diabetes

机译：性腺性腺和糖尿病

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Male hypogonadism is a fairly common occurrence in men with type 2 diabetes mellitus. Testosterone deficiency is associated with reduced insulin sensitivity and several known cardiovascular risk factors, which include visceral obesity, hyper-glycaemia, dyslipidaemia, prothrombotic and pro-inflammatory states and endothelial dysfunction. Low testosterone is an independent risk factor for the development of the metabolic syndrome and type 2 diabetes. The commonest cause of death in a diabetic is cardiovascular disease and testosterone deficiency has been shown to lead to an increase in cardiovascular mortality. Early studies of testosterone replacement therapy in hypogonadal men with type 2 diabetes have reported improvements in insulin resistance, visceral adiposity, cholesterol and glycaemic control. Testosterone replacement also improves sexual function in a group of patients who are known to be difficult to treat.
机译：男性性腺低因素是2型糖尿病的男性相当常见的常见发生。睾酮缺乏与胰岛素敏感性降低和几种已知的心血管危险因素有关，包括内脏肥胖，高血糖血症，血脂血症，孕激酶和促炎状态和内皮功能障碍。低睾酮是一种独立的危险因素，用于发展代谢综合征和2型糖尿病。糖尿病患者中最常见的死因是心血管疾病，并且已经显示出睾酮缺乏导致心血管死亡率的增加。早期研究患有2型糖尿病的低因子男性的睾酮替代疗法已经报道了胰岛素抵抗，内脏肥胖，胆固醇和血糖对照的改善。睾酮替代也改善了一群众所周知的患者中的性功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号